DDDeniz Doğan

Deniz Doğan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deniz Doğan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum Tau and α‐Synuclein in Children With Attention‐Deficit/Hyperactivity Disorder: Cross‐Sectional Associations With Methylphenidate Treatment

    by Deniz Doğan, Elvan İşEri, Aybeniz Civan Kahve, Samet Can Demirci, Dicle Büyüktaşkın, Ahmet Özaslan, Taner Çin, Esra Kara Aşkın, Önder Aydemir, Özlem Gülbahar, et al.

    Objective: To compare serum total tau and α‐synuclein among controls, drug‐naïve children with attention‐deficit/hyperactivity disorder (ADHD) and children with ADHD receiving methylphenidate. Methods: Original ELISA spreadsheets provided 26 controls, 29 evaluable drug‐naïve participants and 32 methylphenidate‐treated participants. Boundary‐coded results (> 500 pg/mL for tau; < 938 pg/mL for α‐synuclein) were assigned the recorded boundary for rank‐based analyses. Groups were compared using Kruskal–Wallis tests and Dunn–Bonferroni contrasts; within‐group associations used Spearman correlations. Results: α‐Synuclein differed among groups ( H = 49.859, p < 0.001, ε 2 = 0.570), with all pairwise contrasts significant. Tau also differed ( H = 10.492, p = 0.005, ε 2 = 0.101); drug‐naïve ADHD had lower tau than controls, whereas the treated group differed from neither comparator after correction. The α‐synuclein–tau correlation remained significant after false‐discovery‐rate adjustment only in drug‐naïve ADHD ( ρ = 0.443, adjusted p = 0.048). Conclusions: Serum α‐synuclein and total tau showed distinct cross‐sectional group patterns. These associations do not establish methylphenidate effects and require prospective confirmation.